Assessment of coronary flow reserve by Doppler flow wIre in patients with acute coronary syndrome undergoing percutaneous coronary intervention: differences between the LoAding dose of Ticagrelor versus prasugrEl (DILATE): study protocol for a randomized controlled trial
暂无分享,去创建一个
F. Fedele | M. Mancone | G. Sardella | V. Maestrini | S. Calcagno | M. Cicenia | A. Cinque | R. Stio | A. Ceccacci | N. Salvi | M. Pulcini
[1] M. Valgimigli,et al. Reducing Microvascular Dysfunction in Revascularized Patients with ST-Elevation Myocardial Infarction by Off-Target Properties of Ticagrelor versus Prasugrel. Rationale and Design of the REDUCE-MVI Study , 2016, Journal of Cardiovascular Translational Research.
[2] Jeroen J. Bax,et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.
[3] Volker Klauss,et al. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial , 2015, The Lancet.
[4] Helmut Baumgartner,et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[5] K. Lackner,et al. Effects of clopidogrel, prasugrel and ticagrelor on endothelial function, inflammatory and oxidative stress parameters and platelet function in patients undergoing coronary artery stenting for an acute coronary syndrome. A randomised, prospective, controlled study , 2014, BMJ Open.
[6] Jeroen J. Bax,et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.
[7] I. Xanthopoulou,et al. Differential Effect of Ticagrelor Versus Prasugrel on Coronary Blood Flow Velocity in Patients With Non–ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Exploratory Study , 2013, Circulation. Cardiovascular interventions.
[8] G. Brandrup-Wognsen,et al. Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans. , 2013, Journal of the American College of Cardiology.
[9] A. Waller,et al. Fractional flow reserve (FFR): changing the practice of interventional cardiology. , 2012, Minerva cardioangiologica.
[10] D. Atar,et al. ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .
[11] J. Sidaway,et al. Ticagrelor Inhibits Adenosine Uptake In Vitro and Enhances Adenosine-Mediated Hyperemia Responses in a Canine Model , 2012, Journal of cardiovascular pharmacology and therapeutics.
[12] K. Ley,et al. Regulation of Neutrophil Function by Adenosine , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[13] B. Olde,et al. Ticagrelor induces adenosine triphosphate release from human red blood cells. , 2012, Biochemical and biophysical research communications.
[14] P. Gurbel,et al. Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses , 2011, Journal of thrombosis and haemostasis : JTH.
[15] D. Schneider. Mechanisms potentially contributing to the reduction in mortality associated with ticagrelor therapy. , 2011, Journal of the American College of Cardiology.
[16] V. Serebruany. Adenosine release: a potential explanation for the benefits of ticagrelor in the PLATelet inhibition and clinical outcomes trial? , 2011, American heart journal.
[17] Claes Held,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.
[18] E. Antman,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.